EPN — Epsilon Healthcare Income Statement
0.000.00%
HealthcareAdventurousMicro Cap
Annual income statement for Epsilon Healthcare, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.95 | 5.5 | 4.65 | 6.65 | 5.6 |
Cost of Revenue | |||||
Gross Profit | 2.34 | 1.92 | 1.24 | 4.81 | 4.17 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17.7 | 17.2 | 19.8 | 9.47 | 10.5 |
Operating Profit | -10.8 | -11.7 | -15.1 | -2.82 | -4.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.5 | -10.1 | -14.1 | -3.31 | -5.57 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.5 | -9.24 | -13.6 | -1.09 | -3.25 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.5 | -9.24 | -13.6 | -1.09 | -3.25 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.5 | -9.24 | -13.6 | -1.09 | -3.25 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.066 | -0.039 | -0.026 | -0.003 | -0.009 |
Dividends per Share |